Literature DB >> 29453917

Comparative chemical investigation and evaluation of antioxidant and tyrosinase inhibitory effects of Withania somnifera (L.) Dunal and Solanum nigrum (L.) berries.

Abdul Hameed1, Naveed Akhtar1.   

Abstract

In the present study, berries of two different species of Solanaceae family, Withania somnifera (WS) and Solanum nigrum (SN), were extracted in methanol and then fractionated with solvents, ranging from non-polar to polar, for their phytochemical profiling and investigation of antioxidant and tyrosinase enzyme inhibition capacity. The methanolic extract and n-hexane, ethyl acetate (WSEA, SNEA) and aqueous fractions were chemically analyzed and evaluated for biological activity. Total flavonoids and total phenolics were quantified in WSEA (96.91 ± 1.56 μg QE mg-1 sample and 178.45 ± 2.78 μg GAE mg-1 s ample, r esp.) and S NEA (89.58 ± 0.98 μg QE mg-1 sample and 120.15 ± 2.33 μg GAE mg-1 sample, resp.). HPLC-DAD analysis of ethyl acetate fractions of WS and SN measured 13.74 and 5.34 μg GAE mg-1 dry fraction and 3.72 and 3.41 μg QE mg-1 dry fraction, resp. WSEA and SNEA fractions showed the highest 2,2-diphenyl-2-picryl hydrazyl (DPPH) radical scavenging, total antioxidant capacity and iron reducing power activity. The highest inhibition of tyrosinase enzyme was also exhibited by WSEA and SNEA (59.6 and 58.7 %) resp. This investigation justifies the medicinal value of W. somnifera and S. nigrum berry extracts as potential and readily available sources of natural antioxidants. Marked tyrosinase enzyme inhibition activity and antioxidant activity of both plant extracts might be due to polyphenols and flavonoids.

Entities:  

Keywords:  HPLC-DAD; Solanum nigrum; Withania somnifera; antioxidant; polyphenols; tyrosinase inhibition

Mesh:

Substances:

Year:  2018        PMID: 29453917     DOI: 10.2478/acph-2018-0007

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  4 in total

Review 1.  A comprehensive review on tyrosinase inhibitors.

Authors:  Samaneh Zolghadri; Asieh Bahrami; Mahmud Tareq Hassan Khan; J Munoz-Munoz; F Garcia-Molina; F Garcia-Canovas; Ali Akbar Saboury
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Telfairia occidentalis stimulates hepatic glycolysis and pyruvate production via insulin-dependent and insulin-independent mechanisms.

Authors:  Toyin Mohammed Salman; Mayowa Adewale Iyanda; Abdul-Musawwir Alli-Oluwafuyi; Sheu Oluwadare Sulaiman; Abdullateef Isiaka Alagbonsi
Journal:  Metabol Open       Date:  2021-04-14

3.  Sodium-calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Henok Kessete Afewerky; Hao Li; Tongmei Zhang; Xinyan Li; Yacoubou Abdoul Razak Mahaman; Limin Duan; Pengwei Qin; Jiequn Zheng; Lei Pei; Youming Lu
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

4.  Withania somnifera (L.) Dunal whole-plant extract demonstrates acceptable non-clinical safety in rat 28-day subacute toxicity evaluation under GLP-compliance.

Authors:  Acharya Balkrishna; Sandeep Sinha; Jyotish Srivastava; Anurag Varshney
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.